Efficacy and Safety of HSK21542 in Inducing Postoperative Analgesia in Undergoing Elective Laparoscopic Surgery
Status:
Completed
Trial end date:
2021-04-28
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, two-stage phase II
clinical study. The main objective is to evaluate the efficacy and safety of HSK21542
injection and explore the recommended dose and administration frequency for subsequent Phase
II studies in conjunction with the pharmacodynamic (PD) and pharmacokinetic (PK)
characteristics.
Phase:
Phase 2
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd. Sichuan Haisco Pharmaceutical Group Co., Ltd.